<DOC>
	<DOC>NCT00700141</DOC>
	<brief_summary>Considering the total number of thyroid procedures in Germany (100000 - 120000 cases per year), TachoSil® is a valuable tool to support surgical haemostasis, avoiding lymph leaks and support speech-nerve saving approaches. The aim of this study was to evaluate a patient and procedure profile where TachoSil® is most beneficial.</brief_summary>
	<brief_title>Non-Interventional Study About Treatment of Hemorrhages in Thyroid Surgery With TachoSil®</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<criteria>Main Patients undergoing total or subtotal thyroidectomy Main Contraindications, such as hypersensitivity to the active pharmaceutical ingredient or to another ingredient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Tachosil</keyword>
	<keyword>thyroid</keyword>
	<keyword>parathyroid</keyword>
	<keyword>fleece-bound hemostasispathologic processes</keyword>
	<keyword>hemorrhage</keyword>
	<keyword>thyroid surgery</keyword>
</DOC>